Penguin AI

Penguin AI is a biotechnology company specializing in the application of generative artificial intelligence for protein design and engineering. Founded by key researchers from Meta's AI division, including lead developers of the ESMFold model, the company leverages large-scale language models to predict protein structures and design novel proteins with specific functions. Their platform aims to accelerate drug discovery and the development of new therapeutic modalities by navigating the vast space of protein sequences more efficiently than traditional methods. The company focuses on building advanced computational models that can be applied across various therapeutic areas, including oncology and immunology. Penguin AI represents a new wave of AI-first biotech firms seeking to make biological design as programmable as software.